ÂÜÀòÂÒÂ×

Troy Hamilton has more than 25 years of experience in the biopharmaceutical and healthcare industries. Currently, he is CEO of Ellodi Pharmaceuticals, a TPG Capital portfolio company. He has held several executive and global commercial leadership roles at Adare Pharmaceuticals, Synergy Pharmaceuticals, Shire Pharmaceuticals, and Johnson & Johnson’s Janssen Pharmaceuticals and McNeil Specialty Products. Troy has significant Gastroenterology-related experience in functional gastrointestinal disorders, inflammatory bowel disease, eosinophilic esophagitis, short bowel syndrome, rare pediatric cholestasis, and acid-peptic disorders. He also serves as a board member at Lazarus Pharmaceuticals and board advisor at New Perspectives, Inc. Troy received his Bachelor of Science and Doctorate degrees in Pharmacy from the University of the Sciences in Philadelphia and his MBA from St. Joseph’s University.